BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37694062)

  • 1. Analog and Digital Protocols for Functional Prosthetic Rehabilitation of Post-COVID-19 Rhino-Orbito Cerebral Mucormycosis Maxillofacial Defects: A Case Series.
    Bhargava A; Soni S; Raj K; Gupta M; Deshpande R; Khan MF
    J Pharm Bioallied Sci; 2023 Jul; 15(Suppl 2):S1347-S1350. PubMed ID: 37694062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
    Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.
    Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S
    J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Prosthodontic Rehabilitation Using Zygomatic Implants in Covid 19 Related Mucormycosis (Rhino-Orbital-Cerebral) Maxillectomy Patients Upon Post-Operative Stress, Anxiety and Functional Impairment: A Prospective Cohort Study.
    Kumar L; Verma A; Pal US; Mattoo K; Algarni YA; Bin Hassan SA; Baba SM; Jeri SY; Khateeb SU
    Clin Interv Aging; 2023; 18():1201-1219. PubMed ID: 37547381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Various Treatment Modalities in COVID-19 Associated Facial Mucormycosis and the Need for its Surgical Management: A Systematic Review.
    Chopra S; Setiya S; Waknis PP; Kale L; Tidke S
    J Maxillofac Oral Surg; 2023 Mar; ():1-22. PubMed ID: 37362874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
    Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.
    Karkhur S; Soni D; Chauhan K; Sarkar D; Gautam M; Verma S; Nyodu R; Yadav N; Sharma B
    Indian J Ophthalmol; 2023 Jan; 71(1):39-56. PubMed ID: 36588206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-COVID-19 rhino-orbito-cerebral mucormycosis-A clinico-mycological study from North India.
    Taneja J; Chatterjee K; Sasidharan J; Abbas SZ; Rai AK; Raychaudhury S; Das B; Das A
    Med Mycol; 2023 Jul; 61(7):. PubMed ID: 37442616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-Covid Cerebral Mucormycosis, Varied Presentations and Surgical Strategies of a Newer Epidemic: An Institutional Experience.
    Vijayasekhar MV; Nagappa V; Swaroop KH; Mithun G; Achuith E; Varaprasad KS
    Neurol India; 2022; 70(3):1052-1056. PubMed ID: 35864638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience.
    Ramamurthy LB; Bhandari R; Kanakpur S; Thejaswini P
    Indian J Ophthalmol; 2022 Mar; 70(3):1019-1024. PubMed ID: 35225564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.
    Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q
    BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive Protein Kinetics During In-Patient Treatment of COVID-19-Associated Rhino-Orbito-Cerebral Mucormycosis: A Retrospective Cohort Study in a Tertiary Hospital in Central India.
    B H S; Bidkar V; Prathipati K; Dabhekar S; Selvaraj K; G D
    Cureus; 2024 Apr; 16(4):e59007. PubMed ID: 38800245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study.
    Cag Y; Erdem H; Gunduz M; Komur S; Ankarali H; Ural S; Tasbakan M; Tattevin P; Tombak A; Ozturk-Engin D; Tartar AS; Batirel A; Tekin R; Duygu F; Caskurlu H; Kurtaran B; Durdu B; Haciseyitoglu D; Rello J;
    Eur J Intern Med; 2022 Jun; 100():56-61. PubMed ID: 35304041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhino-Orbital Cerebral Mucormycosis in a Healthy Female Child: Case Report.
    Yusuf AA; Ibrahim IG; Hirsi IM; Adali A; Hassan YY; Yasar MZ; Abdullahi IM; Hassan MS
    Int Med Case Rep J; 2024; 17():241-246. PubMed ID: 38559497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Mucormycosis in Post COVID-19 Patients and Its Outcome in a Tertiary Care Center: Our Experience.
    Rao KM; Pooja N
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3344-3351. PubMed ID: 36267489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19-Associated Mucormycosis in a Tertiary Care Hospital in India: A Case Series.
    Singh S; Basera P; Anand A; Ozair A
    Cureus; 2022 Aug; 14(8):e27906. PubMed ID: 36110469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
    Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
    Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and its determinants after an outbreak of post COVID-19 associated rhino-orbito-cerebral mucormycosis in Central India.
    Nagarkar NM; Sahu V; Arora R; Pathak M; Shambharkar MS; Naveen P
    Int Ophthalmol; 2023 Jul; 43(7):2363-2370. PubMed ID: 36645635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
    Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
    J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sinonasal and Orbital Imaging Findings in COVID-Associated Rhino-Orbito-Cerebral Mucormycosis During the Second Wave of COVID-19: A Retrospective Cohort Study in a Tertiary Hospital in Central India.
    B H S; Kumbhalkar S; Selvi K; G D; Bidkar V; Dabhekar S; Prathipati K; Sawal A
    Cureus; 2023 Jul; 15(7):e42674. PubMed ID: 37649953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.